NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Tools for Alleviating Drug Disparities in Lipidology
The armamentarium for lipid-lowering pharmacotherapy is evolving. Though statins remain the cornerstone of treatment, and nearly all statins and ezetimibe are generic, recent and emerging…
Understanding Differences in ASCVD Risk and Outcomes in South Asians
A greater prevalence of dyslipidemia, insulin resistance, and atherosclerotic cardiovascular disease (ASCVD) and related-mortality are now well-recognized in South Asians living in the U.S. (SAUS),…
Risk Assessment Tools and Dietary Questionnaires
Risk assessment tools and lifestyle surveys can play a major role in screening patients for risk of atherosclerotic cardiovascular disease (ASCVD), allowing for early targeted…
Racial and Ethnic Differences Associated with Disparities in Lipidology
Concept of Race/Ethnicity: A Social Construct Increasingly, clinicians and public health officials recognize the need to pursue, and potentially achieve, health equity in the United…
S2E6: Women’s Cardiovascular Health
Dr. Alan Brown sits down with Zareen Farukhi, MD, MPH, Associate Physician at Brigham and Women’s Hospital and Instructor at Harvard; and Rachel M. Bond,…
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group
This scientific statement reviews the pre-analytical, analytical, post-analytical, and clinical aspects of lipoprotein measurements.
S2E5: Practical Approaches to Cardiovascular Risk Reduction in the Era of PCSK9 Inhibitors
Dr. Alan Brown sits down with Kim Birtcher, PharmD, CLS, FNLA, Adjunct Clinical Professor at the University of Houston College of Pharmacy, to discuss approaches…